307 results on '"Estall, Jennifer"'
Search Results
2. Is MASLD lost in translation in mice?
3. PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease
4. Identification of biomarkers for glycaemic deterioration in type 2 diabetes
5. Recent Developments in Islet Biology: A Review With Patient Perspectives
6. Islet Biology During COVID-19: Progress and Perspectives
7. Sex-Dependent Hepatoprotective Role of IL-22 Receptor Signaling in Non-Alcoholic Fatty Liver Disease-Related Fibrosis
8. Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases
9. Parvalbumin gates chronic pain through the modulation of firing patterns in inhibitory neurons.
10. PGC-1α isoforms coordinate to balance hepatic metabolism and apoptosis in inflammatory environments
11. PGC1A regulates the IRS1 : IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin
12. Corrigendum to “PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease” [Metabolism Volume 150, January 2024, 155736, PMID: 7967646]
13. PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease
14. Peptide-based sequestration of the adaptor protein Nck1 in pancreatic β cells enhances insulin biogenesis and protects against diabetogenic stresses
15. IL-6 trans-signaling is increased in diabetes, impacted by glucolipotoxicity and associated with liver stiffness and fibrosis in fatty liver disease
16. The pancreas: Bandmaster of glucose homeostasis
17. Estrogen Signals Through Peroxisome Proliferator-Activated Receptor−γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease
18. LIM and cysteine-rich domains 1 (LMCD1) regulates skeletal muscle hypertrophy, calcium handling, and force
19. IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease.
20. PCSK7: a Novel Regulator of Apolipoprotein B and a Potential Target Against Non-Alcoholic Fatty Liver Disease
21. PGC-1 coactivators in β-cells regulate lipid metabolism and are essential for insulin secretion coupled to fatty acids
22. Statins Promote Diabetes by Activating the NLRP3 Inflammasome and Impairing Insulin Secretion.
23. Recent Developments in Islet Biology: A Review With Patient Perspectives
24. The Diabetes-Related Gly482Ser Polymorphism Affects PGC1A Stability and Glucose Metabolism
25. Role of the Interaction Between NCK1 and PERK in Pancreatic Beta-cell Function and Survival
26. β-Aminoisobutyric Acid Induces Browning of White Fat and Hepatic β-Oxidation and Is Inversely Correlated with Cardiometabolic Risk Factors
27. Linking Metabolic Disease With the PGC-1α Gly482Ser Polymorphism
28. PGC-1α4 Interacts with REST to Upregulate Neuronal Genes and Augment Energy Consumption in Developing Cardiomyocytes
29. Parvalbumin protein controls inhibitory tone in the spinal cord
30. Plasma sgp130 is an independent predictor of non-alcoholic fatty liver disease severity
31. A PGC-1α Isoform Induced by Resistance Training Regulates Skeletal Muscle Hypertrophy
32. Development of insulin resistance in mice lacking PGC-1α in adipose tissues
33. 299-OR: Molecular and Physiological Consequences of the Diabetes-Related PGC1A Gly482Ser Polymorphism
34. PGC-1α regulates a HIF2α-dependent switch in skeletal muscle fiber types
35. PGC-1α Negatively Regulates Hepatic FGF21 Expression by Modulating the Heme/Rev-Erbα Axis
36. Transcriptional Control of Adipose Lipid Handling by IRF4
37. The Unfolded Protein Response Mediates Adaptation to Exercise in Skeletal Muscle through a PGC-1α/ATF6α Complex
38. Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases
39. The Gly482Ser Polymorphism Affects PGC-1α Stability in INS-1 β-Cells
40. Role of the Interaction Between Nck1 and PERK in Pancreatic Beta Cell Function and Survival
41. Impact of the PGC-1α Gly482Ser Polymorphism on Mouse Metabolism
42. Loss of hepatic Flcn protects against fibrosis and inflammation by activating autophagy pathways
43. The Tetracycline-Controlled Transactivator (Tet-On/Off) System in Beta Cells Reduces Insulin Expression and Secretion in Mice
44. The Tetracycline-Controlled Transactivator (Tet-On/Off) System in β-Cells Reduces Insulin Expression and Secretion in Mice
45. Phenotypic Characterization of MIP-CreERT1Lphi Mice With Transgene-Driven Islet Expression of Human Growth Hormone
46. To Be(ta Cell) or Not to Be(ta cell): New Mouse Models for Studying Gene Function in the Pancreatic β-Cell
47. ErbB Signaling Is Required for the Proliferative Actions of GLP-2 in the Murine Gut
48. Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol
49. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice
50. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.